Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group
This review examines the growing role of biological therapies in managing severe asthma in children aged 6–11 years. Severe asthma, characterized by persistent symptoms and frequent exacerbations, presents significant challenges in pediatric care. Biologic treatments, including mepolizumab, omalizum...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2025-01-01
|
| Rangatū: | Children |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/2227-9067/12/2/167 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|